We used fibroblast growth factor-8 (FGF-8), which is frequently overexpressed in breast and prostate cancer [9]–[13], as a ligand and FGFR activator to study the functions of FGFR1, 2 and 3. Here, FGF8 is linked to prostate carcinoma.